ARDSLEY, N.Y. (AP) _ Acorda Therapeutics Inc. (ACOR) on Thursday reported a loss of $33.5 million in its first quarter.

On a per-share basis, the Ardsley, New York-based company said it had a loss of $3.53. Losses, adjusted for non-recurring costs and stock option expense, came to $2.46 per share.

The drugmaker posted revenue of $28.9 million in the period.

In the final minutes of trading on Thursday, the company's shares hit $4.70. A year ago, they were trading at $5.16.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACOR at https://www.zacks.com/ap/ACOR

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News